Skip to main content
. Author manuscript; available in PMC: 2014 Jun 10.
Published in final edited form as: J Gene Med. 2014 Jan-Feb;16(0):11–27. doi: 10.1002/jgm.2754

Table 2.

Mean fluorescence intensity (MFI) of EGFP positive, VSV-G infected cells.

Ubi-c Ig Number of independent experiments
Malignant B cells
U266 MM 38.5 (11.52) 311.1(144.48) 4
MM.1S MM 43.6 (18.53) 325.7 (26.98) 3
RPMI 8226 MM 132.5 (30.35) 28.8 (10.91) 3
KMS-11 MM 96.6 (20.05) 46.2 (22.61) 3
Z-138 MCL 13.0 (5.91) 14.9 (5.47) 3
REC-1 MCL 7.0 (0.62) 6.3 (0.71) 5
IM-9 B lymphoblastoid 69.7 (7.25) 23.1 (12.01) 3
Malignant T cells
CCRF-CEM 28.1 (18.88) 12.1 (7.99) 5
MOLT-4 20.2 (7.55) 14.6 (5.95) 5
Jurkat 62.1 (4.69) 43.2 (3.49) 2

Data shown are the average (standard deviation) of the number of experiments indicated. MM: multiple myeloma; MCL: mantle cell lymphoma.